CHRYSTAL MIDDLETON: Open Payments
NPI 1205505799 · CROSSVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,110 in 157 payments from 12 companies in 2025. Trend: 2023 $376 · 2024 $2,206 · 2025 $3,110
Food & beverage: $3,110
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 19 | $489 |
| Vanda Pharmaceuticals Inc. | 16 | $451 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 25 | $435 |
| Otsuka America Pharmaceutical, Inc. | 19 | $378 |
| E.R. Squibb & Sons, L.L.C. | 19 | $338 |
| Alkermes, Inc. | 10 | $224 |
| Teva Pharmaceuticals USA, Inc. | 13 | $205 |
| Axsome Therapeutics, Inc. | 11 | $204 |
| ABBVIE INC. | 11 | $152 |
| Lundbeck LLC | 9 | $140 |
Products named: INGREZZA, CAPLYTA, REXULTI, COBENFY, FANAPT, Auvelity, UZEDY, HETLIOZ.
Industry payments across TN — which companies pay providers there.
